An Uncommon Occurrence of Giant Cell Myocarditis

Authors

  • Althea C. G. Neblett Department of Pathology, University of the West Indies, Mona Campus, Kingston, Jamaica; Forensic Pathology Department, Institute of Forensic Science and Legal Medicine, Kingston, Jamaica

Keywords:

Myocarditis, Giant cell myocarditis, Autopsy, Elderly, Cardiovascular

Abstract

Giant cell myocarditis is a rare condition first described in 1905. It has a reported incidence range from 0.007% to 0.051%. It affects female and male individuals, equally, and usually occurs in young and middle-aged persons. The underlying aetiology of giant cell myocarditis is unknown but it is thought to be mediated by T-lymphocytes. Diagnosis is made via histological examination of myocardial tissue and is characterized by a mixed inflammatory cell infiltrate with multinucleated giant cells and cardiomyocyte necrosis, predominantly affecting the ventricles. The following report describes a rare case of giant cell myocarditis in a 71-year old man with a history of hypertension and heart failure, who died while waiting to be seen in the emergency department. Autopsy findings revealed an enlarged, dilated heart with histologic features in keeping with giant cell myocarditis, along with features of heart failure. Diagnosis of giant cell myocarditis is less common in the elderly age group, possibly due to a less severe disease process in this age group and it may be misdiagnosed because older individuals may have other cardiovascular diseases (CVDs).

References

Myocarditis Foundation. Discover Giant Cell Myocarditis Causes, Symptoms, Diagnosis and Treatment (GCM). Website. https:// www.myocarditisfoundation.org/about-giant-cell-myocarditis/. Accessed April 22, 2020.

Xu J and Brooks E. Giant Cell Myocarditis: A Brief Review. Arch Pathol Lab Med. 2016; 140(12): 1429-1434. doi: 10.5858/arpa.2016- 0068-RS

Kandolin R, Lehtonen J, Salmenkivi K, Räisänen-Sokolowski A, Lommi J, Kupari M. Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression. Circ Heart Fail. 2013; 6: 15-22. doi: 10.1161/ CIRCHEARTFAILURE.112.969261

Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant cell myocarditis. Natural history and treatment. Multicenter Giant Cell Submit your article to this journal | https://openventio.org/submit-manuscript/ 10 Neblett ACG Myocarditis Study Group Investigators. N Engl J Med. 1997; 336: 1860-1866. doi: 10.1056/NEJM199706263362603

Doughan AR, Williams BR. Cardiac sarcoidosis. Heart. 2006; 92(2): 282-288. doi: 10.1136/hrt.2005.080481

National Organization of Rare Disorders. Giant Cell Myocarditis. Website. https://rarediseases.org/rare-diseases/ giant-cell-myocarditis/. 2018; Accessed December 3, 2019.

Loughrey M, McCluggage W, and Toner P. The declining autopsy rate and clinicians’ attitudes. Ulster Med J. 2000; 69(2): 83-89.

Shashi Ariyanayagam-Baksh. Final Diagnosis: Idiopathic Giant Cell Myocarditis. Website. https://path.upmc.edu/cases/case175/ dx.html. Accessed April 21, 2020.

Whitehead R. Isolated myocarditis. Br Heart J. 1965; 27(2): 220- 230. doi: 10.1136/hrt.27.2.220

Al-Aqeedi R. Diagnosis and Treatment of Myocarditis. Web site. https://www.intechopen.com/books/diagnosis-and-treatment-of-myocarditis/dtm-clinical-presentation. Accessed June 2, 2020.

Okura Y, Dec GW, Hare JM, Kodama M, Berry GJ, Tazelaar HD, et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol. 2003; 41(2): 322-328. doi: 10.1016/s0735-1097(02)02715-8

Fernández-Yáñez J, Palomo J, Muñoz P, Salinero E, Lima P, Vallbonae B, et al. Miocarditis de células gigantes. Presentación de un caso. Revista Española de Cardiología. 2002; 55(6): 678-681. doi: 10.1016/S0300-8932(02)76677-3

Ekström K, Lehtonen J, Kandolin K, Räisänen-Sokolowski A, Salmenkivi K, Kupari M, et al. Long-term outcome and its predictors in giant cell myocarditis. Eur J Heart Fail. 2016; 18: 1452- 1458. doi: 10.1002/ejhf.606

Okuda K, Ying Fu H, Tsuchida S, Yamato M, Araki R, Matsuzaki T, et al. Immunosuppressive therapy for giant-cell myocarditis with nanotechnology. J Card Fail. 2015: 21(10): (S188). doi: 10.1016/j. cardfail.2015.08.245

Larsen BT, Maleszewski JJ, Edwards WD, Cooper LT Jr, Sobonya RE, Thompson VE, et al. Atrial giant cell myocarditis: A distinctive clinicopathologic entity. Circulation. 2013; 127: 39-47. doi: 10.1161/CIRCULATIONAHA.112.128900

Downloads

Published

2025-04-12

How to Cite

Althea C. G. Neblett. (2025). An Uncommon Occurrence of Giant Cell Myocarditis. Heart Research, 12(1), 7–10. Retrieved from https://openventio.us/index.php/HROJ/article/view/2246

Similar Articles

<< < 1 2 3 4 

You may also start an advanced similarity search for this article.